Discovery of gallic acid-based mitochondriotropic antioxidant attenuates LPS-induced neuroinflammation
- 19 November 2024
- journal article
- research article
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 226, 302-329
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Cellular Red-Ox system in health and disease: The latest updateBiomedicine & Pharmacotherapy, 2023
- Mitochondria targeting drugs for neurodegenerative diseases—Design, mechanism and applicationActa Pharmaceutica Sinica B, 2022
- Mitochondriotropic antioxidant based on caffeic acid AntiOxCIN4 activates Nrf2-dependent antioxidant defenses and quality control mechanisms to antagonize oxidative stress-induced cell damageFree Radical Biology and Medicine, 2022
- Inflammation and mitochondrial dysfunction: A vicious circle in neurodegenerative disorders?Neuroscience Letters, 2019
- First line defence antioxidants-superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPX): Their fundamental role in the entire antioxidant defence gridAlexandria Journal of Medicine, 2018
- Mitochondria-Targeted Triphenylphosphonium-Based Compounds: Syntheses, Mechanisms of Action, and Therapeutic and Diagnostic ApplicationsChemical Reviews, 2017
- The role of mitochondria in metabolism and cell deathBiochemical and Biophysical Research Communications, 2017
- Free Radicals: Properties, Sources, Targets, and Their Implication in Various DiseasesIndian Journal of Clinical Biochemistry, 2014
- Comparison of ABTS/DPPH assays to measure antioxidant capacity in popular antioxidant-rich US foodsJournal of Food Composition and Analysis, 2011
- Synthesis and antitumor evaluation of a novel series of triaminotriazine derivativesBioorganic & Medicinal Chemistry, 2007